Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Dec 1;14(23):7967-71.
doi: 10.1016/j.bmc.2006.07.052. Epub 2006 Aug 10.

Carbocyclic pyrimidine nucleosides as inhibitors of S-adenosylhomocysteine hydrolase

Affiliations

Carbocyclic pyrimidine nucleosides as inhibitors of S-adenosylhomocysteine hydrolase

Sylvester L Mosley et al. Bioorg Med Chem. .

Abstract

The design, synthesis, and unexpected inhibitory activity against S-adenosyl-homocysteine (SAH) hydrolase (SAHase, EC 3.3.1.1) for a series of truncated carbocyclic pyrimidine nucleoside analogues is presented. Of the four nucleosides obtained, 10 was found to be active with a Ki value of 5.0 microM against SAHase.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Potent Carbocylic SAHase Inhibitors.
Figure 2
Figure 2
Carbocylic derivatives of uridine and cytidine
Figure 3
Figure 3
Carbocylic Targets.
Figure 4
Figure 4
Inhibition of SAHase by 10. Assay solutions contained 50 mM potassium phosphate at pH 7.4, 0.39 units of adenosine deaminase, 132 nM of SAHase, 10 μM of SAH (substrate), and various concentrations of 10. Consumption of substrate was monitored at 265 nm.
Figure 5
Figure 5
Inhibition of SAHase by 10. In the assay solution, the concentration of 10 was held constant at 45 μM while the concentration of substrate was varied. Rates in the presence (data points at bottom of plot) and absence (data points at top of plot) of inhibitors were measured.
Scheme 1
Scheme 1
Reagents and comditions: (a) i. N3-Bz-uracil, PPh3, DIAD, CH3CN, 0 °C to rt, 70%, ii. NaOH in MeOH (1%),rt, 15h, 75%: (b) TFA:H2O (2:1), rt, 3h, 95%; (c) i. TIPBSCI, NEt3, DMAP, CH3CN, rt, 4 h; ii. NH4OH, rt, 15 h, 65%.
Scheme 2
Scheme 2
Reagents and conditions: (a) H2 (25 psi), Pd/C, EtOH, rt, 30 min, quant.; (b) TFA/H2O (2:1), rt, 3 h, 95%; (c) i. TIPBSCI, NEt3, DMAP, CH3CN, rt, 4 h; ii. NH4OH, rt, 15 h, 65%.

Similar articles

Cited by

References

    1. De Clercq E. Biochem Pharmacol. 1987;36:2567–2575. - PubMed
    1. De Clercq E. Nucleosides & Nucleotides. 1994;13:1271–1295.
    1. De Clercq E. Nucleosides & Nucleotides. 1998;17:625–634. - PubMed
    1. Seley KL, Quirk S, Salim S, Zhang L, Hagos A. Bioorganic Med Chem Lett. 2003;13:1985–1988. - PubMed
    1. De Clercq E. Clinical Microbiol Rev. 2001;14:382–397. - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources